Infectious Diseases

Experimental Drug Effectively Treats S. Aureus Infections

08/28/2015

Edmund J. Lavoie, PhD, discusses the unique pharmacokinetic properties of the experimental drug TXA-709 that may allow it to effectively treat Staphylococcus aureus infections, including MRSA, while reducing the possibility of patients developing antibiotic resistance.

For more videos, visit our partners at The Doctor's Channel.

Related Content

Diabetes
Diabetes
Anne Peters, MD, on Medical Devices for Managing Type 2 Diabetes
07/01/2021
In this video, Anne Peters, MD, discusses the present and future of medical devices used to treat patients with type 2 diabetes. She also spoke about this topic at our Practical Updates in Primary Care...
07/01/2021
Surgical Wound Management
Julie Allickson, PhD
Surgical Wound Management
Tissue Engineered Structures Require Complex Manipulation
04/09/2019
Julie Allickson, PhD, director of the Wake Forest University School of Medicine’s Regenerative Medicine Clinical Center, discusses emerging research on regenerative medicine applications, such as...
04/09/2019
Nutrition
Timothy S. Harlan and Leah Sarris
Nutrition
CRS 2015: Advice on Patient Nutrition Counseling
09/27/2015
Summit Co-Chair Timothy S. Harlan, MD, Assistant Dean for Clinical Services, Executive Director, Goldring Center for Culinary Medicine, Associate Professor of Medicine, Tulane University School of Medicine...
09/27/2015
Gastroenterology
video
Gastroenterology
What are the risks of malignancies due to having IBD and being on immunomodulators and/or biologics: How can we help our patients avoid those risks?
08/07/2018
08/07/2018
Cardiology
Cardiology
Is Advanced Cardiovascular Imaging the Key to More Accurate Diagnoses?
04/23/2015
Szilard Voros, MD, discusses the immense obstacles to efficiently diagnosing cardiovascular disease, the development of a blood test with a quick turnaround time that will identify a negative test to 95%...
04/23/2015